The Cellular Oncogene c-myb Can Interact Synergistically with the Epstein-Barr Virus BZLF1 Transactivator in Lymphoid Cells

References

• Bender, T., and M. Kuehl. 1987. Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors. J. Immunol. 139:3822–3827.
   PubMedGoogle Scholar
• Biedenkapp, H., U. Borgmeyer, A. E. Sippel, and K. H. Klempnauer. 1988. Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature (London) 335:835–837.
   PubMed Web of Science ®Google Scholar
• Boyle, W., J. Lipsick, and M. Baluda. 1986. Antibodies to the evolutionarily conserved amino-terminal region of the v-myb- encoded protein detect the c-myb protein in widely divergent metazoan species. Proc. Natl. Acad. Sci. USA 83:4685–4689.
   PubMedGoogle Scholar
• Chang, Y.-N., D. Dong, G. Hayward, and S. D. Hayward. 1990. The Epstein-Barr virus Zta transactivator: a member of the bZip family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J. Virol. 64:3358–3369.
   PubMed Web of Science ®Google Scholar
• Chevallier-Greco, A., H. Gruffat, E. Manet, A. Calender, and A. Sergeant. 1989. The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. J. Virol. 63:615–623.
   PubMedGoogle Scholar
• Chevallier-Greco, A., H. Gruffat, E. Manet, P. Chavrier, C. Mosnier, J. Daillie, and A. Sergeant. 1986. Both Epstein-Barr virus (EBV)-encoded transactivators, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 5:3243–3249.
   PubMed Web of Science ®Google Scholar
• Countryman, J., H. Jenson, R. Seibl, H. Wolf, and G. Miller. 1987. Polymorphic proteins encoded within the BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J. Virol. 61:3672–3679.
   PubMed Web of Science ®Google Scholar
• Cox, M. A., J. Leahy, and J. M. Hardwick. 1990. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol. 64:313–321.
   PubMedGoogle Scholar
• Diamond, M., J. Miner, S. Yoshinaga, and K. Yamamoto. 1990. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266–1272.
   PubMed Web of Science ®Google Scholar
• Evans, J. L., T. L. Moore, W. M. Kuehl, T. Bender, and J. P.-Y. Ting. 1990. Functional analysis of c-Myb protein in T-lympho- cytic cell lines shows that it trans-activates the c-myc promoter. Mol. Cell. Biol. 10:5747–5752.
   PubMedGoogle Scholar
• Farrell, P., D. Rowe, C. Rooney, and J. T. Kouzarides. 1989. Epstein-Barr virus BZLF1 trans-activator specifically binds to consensus AP-1 site and is related to c-fos. EMBO J. 8:127–132.
   PubMed Web of Science ®Google Scholar
• Favaloro, J., R. Treisman, and R. Kamen. 1980. Transcription maps of polyoma virus-specific RNA; analysis by two dimensional S1 gel mapping. Methods Enzymol. 65:718–728.
   PubMedGoogle Scholar
• Flemington, E., and S. H. Speck. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227–1232.
   PubMedGoogle Scholar
• Garcia, A., K. Montagne, D. Reavis, U. Stober-Grasser, and J. Lipsick. 1991. Determinants of sequence-specific DNA-binding by p48 v-myb. Oncogene 6:265–273.
   PubMedGoogle Scholar
• Gilman, M. 1988. Preparation of cytoplasmic RNA from tissue culture cells, p. 4.1.2–4.1.6. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York.
   Google Scholar
• Giot, J.-F., I. Mikaelian, M. Buisson, E. Manet, I. Joab, J.-C. Nicolas, and A. Sergeant. 1991. Transcriptional synergy and interference between the EBV transcription factors EB1 and R require both the basic region and the activation domain 2 of EB1. Nucleic Acids Res. 19:1251–1258.
   PubMedGoogle Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Gregory, C., C. Kirchgens, C. Edwards, L. Young, M. Rowe, A. Forster, T. Rabbits, and A. Rickenson. 1987. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes. Eur. J. Immunol. 17:1199–1207.
   PubMed Web of Science ®Google Scholar
• Gruffat, H., E. Manet, A. Rigolet, and A. Sergeant. 1990. The enhancer factor R of Epstein-Barr virus (EBV) is a sequencespecific DNA binding protein. Nucleic Acids Res. 18:6835–6843.
   PubMedGoogle Scholar
• Gutsch, D. Unpublished data.
   Google Scholar
• Hardwick, J. M., P. Lieberman, and S. D. Hayward. 1988. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol. 62:2274–2284.
   PubMedGoogle Scholar
• Holley-Guthrie, E., E. B. Quinlivan, E.-C. Mar, and S. Kenney. 1990. The Epstein-Barr virus promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J. Virol. 64:3753–3759.
   PubMedGoogle Scholar
• Howe, K. M., C. F. L. Reakes, and R. J. Watson. 1990. Characterization of the sequence-specific interaction of mouse c-myb protein with DNA. EMBO J. 9:161–169.
   PubMed Web of Science ®Google Scholar
• Ibanez, C., and J. Lipsick. 1988. Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation. J. Virol. 62:1981–1988.
   PubMedGoogle Scholar
• Ibanez, C., and J. Lipsick. 1990. Transactivation of gene expression by v-myb. Mol. Cell. Biol. 10:2285–2293.
   PubMed Web of Science ®Google Scholar
• Introna, M., J. Golay, J. Frampton, T. Nakano, S. Ness, and T. Graf. 1990. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63:1287–1297.
   Google Scholar
• Kenney, S. Unpublished data.
   Google Scholar
• Kenney, S., E. Holley-Guthrie, E. C. Mar, and M. Smith. 1989. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol. 63:3878–3883.
   PubMed Web of Science ®Google Scholar
• Klempnauer, K.-H., H. Arnold, and H. Biedenkapp. 1989. Activation of transcription by v-myb: evidence for two different mechanisms. Genes Dev. 3:1582–1589.
   PubMedGoogle Scholar
• Klempnauer, K.-H., and A. E. Sippel. 1987. The highly conserved amino-terminal region of the protein encoded by the v-myb oncogene functions as a DNA-binding domain. EMBO J. 6:2719–2725.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T., G. Packham, A. Cook, and P. Farrell. 1991. The BZLF1 protein of EBV has a coiled coil dimerization domain without a heptad leucine repeat but homology to the C/EBP leucine zipper. Oncogene 6:195–204.
   PubMedGoogle Scholar
• Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488–492.
   PubMed Web of Science ®Google Scholar
• Laimins, L., P. Gruss, R. Pozatti, and G. Khoury. 1984. Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus. J. Virol. 49:183–189.
   PubMed Web of Science ®Google Scholar
• Lane, T., C. Ibanez, A. Garcia, T. Graf, and J. Lipsick. 1990. Transformation by v-myb correlates with transactivation of gene expression. Mol. Cell. Biol. 10:2591–2598.
   PubMedGoogle Scholar
• Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741–752.
   PubMed Web of Science ®Google Scholar
• Li, R., J. Knight, S. Jackson, R. Tjian, and M. Botchan. 1991. Direct interaction between the Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 65:493–505.
   PubMedGoogle Scholar
• Lieberman, P., and A. Berk. 1990. In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J. Virol. 64:2560–2568.
   PubMed Web of Science ®Google Scholar
• Lillie, J., and M. Green. 1989. Transcription activation by the adenovirus E1a protein. Nature (London) 338:39–44.
   PubMedGoogle Scholar
• Lipsick, J. S., and W. J. Boyle. 1987. c-myb expression is a late event during T-lymphocyte activation. Mol. Cell. Biol. 7:3358–3360.
   PubMedGoogle Scholar
• Luscher, B., and B. Eisenman. 1990. New light on myc and myb. Part II. Myb. Genes Dev. 4:2235–2241.
   PubMed Web of Science ®Google Scholar
• Mizuguchi, G., H. Nakagoshi, T. Nagase, N. Nomura, T. Date, Y. Ueno, and S. Ishii. 1990. DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-myb. J. Biol. Chem. 265:9280–9284.
   PubMed Web of Science ®Google Scholar
• Nakagoshi, H., T. Nagase, Y. Ueno, and S. Ishii. 1989. Transcriptional transrepression by the c-myb proto-oncogene product. Nucleic Acids Res. 17:7315–7324.
   PubMedGoogle Scholar
• Nishina, Y., H. Nakagoshi, F. Imamoto, T. J. Gonda, and S. Ishii. 1989. Trans-activation by the c-myb proto-oncogene. Nucleic Acid Res. 17:107–117.
   PubMedGoogle Scholar
• Nomura, N., M. Takahashi, M. Matsui, S. Ishii, T. Date, S. Sasamoto, and R. Ishizaki. 1988. Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acid Res. 16:11075–11085.
   PubMed Web of Science ®Google Scholar
• Packham, G., A. Economou, C. Rooney, D. Rowe, and P. Farrell. 1990. Structure and function of the Epstein-Barr virus BZLF1 protein. J. Virol. 64:2110–2116.
   PubMed Web of Science ®Google Scholar
• Quinlivan, E., et al. Submitted for publication.
   Google Scholar
• Rooney, C., N. Taylor, J. Countryman, H. Jenson, J. Kolman, and G. Miller. 1988. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc. Natl. Acad. Sci. USA 85:9801–9805.
   PubMedGoogle Scholar
• Rooney, C. M., D. T. Rowe, T. Ragot, and P. J. Farrell. 1989. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J. Virol. 63:3109–3116.
   PubMed Web of Science ®Google Scholar
• Sakura, H., C. Kanei-Ishii, T. Nagase, H. Nakagoshi, T. Gonda, and S. Ishii. 1989. Delineation of three functional domains of the transcriptional activator encoded by the c-myb proto-oncogene. Proc. Natl. Acad. Sci. USA 86:5758–5762.
   PubMed Web of Science ®Google Scholar
• Shen-ong, G., B. Luscher, and R. Eisenman. 1989. A second c-myb protein is translated from an alternatively spliced mRNA expressed from normal and 5' disrupted myb loci. Mol. Cell. Biol. 9:5456–5463.
   PubMedGoogle Scholar
• Takada, K., N. Shimuzu, S. Sakuma, and Y. Ono. 1986. Transactivation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J. Virol. 57:1016–1022.
   PubMed Web of Science ®Google Scholar
• Takimoto, T., H. Ogura, H. Sato, R. Umeda, and M. Hatano. 1985. Isolation of transforming and early antigen-producing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). J. Natl. Cancer Inst. 74:57–59.
   PubMedGoogle Scholar
• Taylor, N., E. Flemington, J. Kolman, R. Baumann, S. Speck, and G. Miller. 1991. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein- Barr virus BZLF1 promoter. J. Virol. 65:4033–4041.
   PubMedGoogle Scholar
• Thiele, C., P. S. Cohen, and M. S. Israel. 1988. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol. Cell. Biol. 8:1677–1683.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B., P. B. Chailoner, P. E. Neiman, and M. Groudine. 1986. Expression of the c-myb proto-oncogene during cellular proliferation. Nature (London) 319:374–380.
   PubMed Web of Science ®Google Scholar
• Tice-Baldwin, K., G. Fink, and K. Arndt. 1989. BAS1 has an Myb motif and activates HIS4 transcription only in combination with BAS2. Science 246:931–935.
   PubMedGoogle Scholar
• Tonneguzzo, F., A. C. Hayday, and A. Keating. 1986. Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells. Mol. Cell. Biol. 6:703–706.
   PubMedGoogle Scholar
• Urier, G., M. Buisson, P. Chambard, and A. Sergeant. 1989. The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO J. 8:1447–1453.
   PubMedGoogle Scholar
• Vinson, C. R., P. B. Sigler, and S. L. McKnight. 1989. Scissors- grip model for DNA recognition by a family of leucine zipper proteins. Science 246:911–916.
   PubMed Web of Science ®Google Scholar
• Weber, B., E. Westin, and M. Clarke. 1990. Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA. Science 249:1291–1293.
   PubMedGoogle Scholar
• Westin, E., K. Gorse, and M. Clarke. 1990. Alternative splicing of the human c-myb gene. Oncogene 5:1117–1124.
   PubMedGoogle Scholar
• Weston, K., and J. M. Bishop. 1989. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58:85–93.
   PubMed Web of Science ®Google Scholar
• Yang-Yen, H.-F., J.-C. Chambard, Y.-L. Sun, T. Smeal, T. Schmidt, J. Drouin, and M. Karin. 1990. Transcription interference between c-Jun and glucocorticoid receptor: mutual inhibition of DNA-binding due to direct protein-protein interaction. Cell 62:1205–1215.
   PubMed Web of Science ®Google Scholar